Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Ramsay

Showing results (261-270 of 279) with videos related to

Pageof 28
Sort By:
Trials|January 18, 2023
Phlebotomy resulting in controlled hypovolemia to prevent blood loss in major hepatic resections (PRICE-2): study protocol for a phase 3 randomized controlled trialGuillaume Martel, Tori Lenet, Christopher Wherrett, et al.
Frontiers in Immunology|February 5, 2025
Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infectionsDana Unninayar, Emilia L Falcone, Hugo Chapdelaine, et al.
Eclinicalmedicine|March 8, 2021
Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trialDugald Seely, Mark Legacy, Rebecca C Auer, et al.
The New England Journal of Medicine|June 10, 2026
Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac SurgeryBrett L Houston, Daniel I McIsaac, Rodney H Breau, et al.
Journal of Clinical Immunology|April 25, 2026
Three Doses and Six Months Later: Real-World SARS-CoV-2 Specific Humoral and Cell-Mediated Immunity in Children With Inborn Errors of ImmunityLuana L T N Porto, Dina Yazji, Dana Unninayar, et al.
Annals of Internal Medicine|November 22, 2021
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort StudyGrégoire Le Gal, Michael J Kovacs, Laurent Bertoletti, et al.
Neurology|August 3, 2019
New and expanding ventricular hemorrhage predicts poor outcome in acute intracerebral hemorrhageVignan Yogendrakumar, Tim Ramsay, Dean Fergusson, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 24, 2021
Trends in Diagnosis of Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features and Total Thyroidectomies for Patients With Papillary Thyroid NeoplasmsLisa Caulley, Antoine Eskander, Weining Yang, et al.
The New England Journal of Medicine|March 11, 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous ThromboembolismLana A Castellucci, Vivien M Chen, Michael J Kovacs, et al.
The New England Journal of Medicine|December 10, 2024
Liberal or Restrictive Transfusion Strategy in Aneurysmal Subarachnoid HemorrhageShane W English, Anthony Delaney, Dean A Fergusson, et al.
Pageof 28

Showing results (261-270 of 279) with videos related to

Sort By:
Pageof 28
Trials|January 18, 2023
Phlebotomy resulting in controlled hypovolemia to prevent blood loss in major hepatic resections (PRICE-2): study protocol for a phase 3 randomized controlled trialGuillaume Martel, Tori Lenet, Christopher Wherrett, et al.
Frontiers in Immunology|February 5, 2025
Humoral and cell-mediated immune responses to COVID-19 vaccines up to 6 months post three-dose primary series in adults with inborn errors of immunity and their breakthrough infectionsDana Unninayar, Emilia L Falcone, Hugo Chapdelaine, et al.
Eclinicalmedicine|March 8, 2021
Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trialDugald Seely, Mark Legacy, Rebecca C Auer, et al.
The New England Journal of Medicine|June 10, 2026
Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac SurgeryBrett L Houston, Daniel I McIsaac, Rodney H Breau, et al.
Journal of Clinical Immunology|April 25, 2026
Three Doses and Six Months Later: Real-World SARS-CoV-2 Specific Humoral and Cell-Mediated Immunity in Children With Inborn Errors of ImmunityLuana L T N Porto, Dina Yazji, Dana Unninayar, et al.
Annals of Internal Medicine|November 22, 2021
Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort StudyGrégoire Le Gal, Michael J Kovacs, Laurent Bertoletti, et al.
Neurology|August 3, 2019
New and expanding ventricular hemorrhage predicts poor outcome in acute intracerebral hemorrhageVignan Yogendrakumar, Tim Ramsay, Dean Fergusson, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 24, 2021
Trends in Diagnosis of Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features and Total Thyroidectomies for Patients With Papillary Thyroid NeoplasmsLisa Caulley, Antoine Eskander, Weining Yang, et al.
The New England Journal of Medicine|March 11, 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous ThromboembolismLana A Castellucci, Vivien M Chen, Michael J Kovacs, et al.
The New England Journal of Medicine|December 10, 2024
Liberal or Restrictive Transfusion Strategy in Aneurysmal Subarachnoid HemorrhageShane W English, Anthony Delaney, Dean A Fergusson, et al.
Pageof 28